-
Mashup Score: 2TMIST breast cancer screening trial enrollment surpasses 100,000 - 6 month(s) ago
Milestone is reached despite the lingering impact of the worldwide pandemic on breast cancer screenings
Source: ecog-acrin.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Press Release: NCI-MATCH cancer trial discovers a potentially broader role for an established dual HER2-blocking treatment - 9 month(s) ago
Trastuzumab-pertuzumab is FDA-approved for patients with HER2-positive breast cancer, with minimal side effects. The NCI-MATCH precision medicine trial saw it shrink tumors in several other cancer types.
Source: ecog-acrin.orgCategories: General Medicine News, Hem/OncsTweet-
https://t.co/jlOMfTMcJt
-
-
Mashup Score: 15Home - 1 year(s) ago
DYK patients with #SolidTumors who previously had taxane therapy in the metastatic setting may be eligible for #ComboMATCH Treatment Trial E4? This study is testing combination therapy w/ nilotinib and paclitaxel. More: https://bit.ly/cmatch-e4 cc: @NCItreatment #PrecisionMedicine …
Source: ecog-acrin.orgCategories: General Medicine News, Hem/OncsTweet-
ECOG ACRIN group meeting starts tomorrow. For me it’s myeloma trial discussions for next 3 days! #MedTwitter @eaonc @SagarLonialMD @myelomaMD @nsc_natalie @mtmdphd @NorthTxMSG https://t.co/WpfIOWgVQH
-
-
Mashup Score: 1Clinical Trials - 1 year(s) ago
VariousEAY191 / ComboMATCHPatients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or other places in the body (advanced)Patient RegistrationDevelopmental Therapeutics VariousEAY191-E4Metastatic (advanced) solid tumors that are progressing after treatment with taxane chemotherapyTreatmentDevelopmental Therapeutics …
Source: ecog-acrin.orgCategories: General Medicine News, Hem/OncsTweet-
. @eaonc Active #ClinicalTrials https://t.co/25HrOKq3On #ctsm
-
-
Mashup Score: 0Social Genomic Mechanisms of Health Disparities Among Adolescent and Young Adult (AYA) Survivors of Hodgkin and Non-Hodgkin Lymphoma - 1 year(s) ago
Identifying genomic pathways through which post-treatment survivorship can be influenced by psychosocial and environmental factors
Source: ecog-acrin.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @BradZebrack: https://t.co/Ikv8jvee8S @eaonc ECOG-ACRIN NCORP trial EAQ211 Active NOW!
-
RT @eaonc: TMIST #BreastCancer screening trial enrollment surpasses 100,000! Read the press release here 👉https://t.co/Xa18DUY4W6 cc: @etpi…